NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Anivive Lifesciences

Anivive Lifesciences

Private
Long Beach, CaliforniaHealthcare & Life Scienceshttps://www.anivive.com/

Last Round

Debt

Jan 27, 2025

Total Funding Raised

$98.5M

Company Overview

Anivive Lifesciences is a biotechnology company that develops therapeutics for animals.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

pet pharmaveterinary therapeuticscompanion animal healthAI drug discoveryveterinary oncologydrug repurposingantifungal vaccineValley Fever vaccinecanine lymphoma treatmentdirect-to-vetvet techmedical AItumor genomic sequencingFIP treatmentFeline Infectious Peritonitis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anivive Lifesciences Comparables

Compare Anivive Lifesciences with similar companies based on industry and business-model similarity.

Anivive Lifesciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Animal Life Sciences
79%
Torigen Pharmaceuticals, Inc.
79%
Elanco
79%

Anivive Lifesciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJan 27, 2025
GrantAug 2, 2024
GrantJul 8, 2021
Series CApr 11, 2021

Key People

Founding team and executive leadership

Dylan Balsz

Founder, CEO And Chairman

Founding Team

Cody Arbuckle

Chief Technology Officer

Executive Team

Anivive Lifesciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2026

    Monthly visitors increased 55% MoM.

  • Mar 26, 2025

    Monthly visitors increased 58% MoM, from 7.3K to 11.5K.

Anivive Lifesciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anivive Lifesciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anivive Lifesciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersLong Beach, California
Employee Range24
Year Founded2015
Last FundingJan 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.